China's Harbin Pharma to buy stake in U.S. health retailer GNC: Reuters

China’s state-controlled drugmaker Harbin Pharmaceutical Group Holding Co (600664.SS) will buy an about 40 percent stake in U.S. nutritional supplements retailer GNC Holdings Inc (GNC.N) for $300 million and are in talks for a joint venture in China, the companies said.